Sw. Graves et al., A LABILE SODIUM-PUMP INHIBITOR FROM THE PERITONEAL DIALYSATE OF HYPERTENSIVE RENAL-FAILURE PATIENTS - ESTIMATES OF POTENCY, Clinical and experimental hypertension, 20(5-6), 1998, pp. 611-616
Estimations of concentration of the labile sodium pump inhibitor isola
ted from human peritoneal dialysate were made using supercritical flui
d chromatography coupled to flame ionization detection to determine th
e quantity of this factor in half of a purified preparation of the fac
tor compared to the bioactivity of the other half in different assays.
Ouabain was used for comparison. The labile factor appeared to be 30
times more effective than ouabain against canine renal [Na,K]ATPase. M
oreover, this same factor appeared to be similar to 1,000 times more p
otent than ouabain in causing vascular smooth muscle contraction. The
differences between this labile sodium pump inhibitor and ouabain most
likely reflect their respective binding affinities. The assay differe
nces in half maximal response to the labile sodium pump inhibitor may
be due to differences in sodium pump alpha isoform sensitivity.